180 related articles for article (PubMed ID: 36319797)
1. Metabolic-associated fatty liver disease increases the risk of end-stage renal disease in patients with biopsy-confirmed diabetic nephropathy: a propensity-matched cohort study.
Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhao Y; Xu H; Li L; Tong N; Liu F
Acta Diabetol; 2023 Feb; 60(2):225-233. PubMed ID: 36319797
[TBL] [Abstract][Full Text] [Related]
2. Serum transferrin predicts end-stage Renal Disease in Type 2 Diabetes Mellitus patients.
Zhao L; Zou Y; Zhang J; Zhang R; Ren H; Li L; Guo R; Zhang J; Liu F
Int J Med Sci; 2020; 17(14):2113-2124. PubMed ID: 32922172
[No Abstract] [Full Text] [Related]
3. Clinicopathologic features and prognostic factors in older patients with biopsy-proven diabetic nephropathy.
Zhao L; Ren H; Zhang R; Wang T; Zou Y; Xu H; Li L; Cooper ME; Liu F
Int Urol Nephrol; 2021 Jun; 53(6):1161-1170. PubMed ID: 33389518
[TBL] [Abstract][Full Text] [Related]
4. Aspartate aminotransferase to alanine aminotransferase ratio and the risk of diabetic nephropathy progression in patients with type 2 diabetes mellitus: A biopsy-based study.
Wu Y; Liu F
J Diabetes Complications; 2022 Aug; 36(8):108235. PubMed ID: 35853763
[TBL] [Abstract][Full Text] [Related]
5. The impact of concomitant metabolic dysfunction-associated fatty liver disease on adverse outcomes in patients with hepatitis B cirrhosis: a propensity score matching study.
Wang X; Wei S; Wei Y; Wang X; Xiao F; Feng Y; Zhu Q
Eur J Gastroenterol Hepatol; 2023 Aug; 35(8):889-898. PubMed ID: 37395242
[TBL] [Abstract][Full Text] [Related]
6. Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy.
Yamanouchi M; Hoshino J; Ubara Y; Takaichi K; Kinowaki K; Fujii T; Ohashi K; Mise K; Toyama T; Hara A; Kitagawa K; Shimizu M; Furuichi K; Wada T
PLoS One; 2018; 13(1):e0190930. PubMed ID: 29338014
[TBL] [Abstract][Full Text] [Related]
7. Glomerular basement membrane duplication is a predictor of the prognosis of diabetic nephropathy in patients with type 2 diabetes.
Yamakawa T; Kawaguchi T; Kitamura H; Kadomura M; Nishimura M; Yokoo T; Imasawa T
Clin Exp Nephrol; 2019 Apr; 23(4):521-529. PubMed ID: 30467801
[TBL] [Abstract][Full Text] [Related]
8. Plasma D-dimer levels are associated with disease progression in diabetic nephropathy: a two-center cohort study.
Yu Y; Zhu C; Lin Y; Qian Q; Shen X; Zou W; Wang M; Gong J; Chen M; Liu L; Yu R; Shen Q; Shao L; Zhu B
Ren Fail; 2023; 45(2):2285868. PubMed ID: 38013428
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Nutritional Index as a Predictor of Diabetic Nephropathy Progression.
Zhang J; Xiao X; Wu Y; Yang J; Zou Y; Zhao Y; Yang Q; Liu F
Nutrients; 2022 Sep; 14(17):. PubMed ID: 36079889
[TBL] [Abstract][Full Text] [Related]
10. Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy.
Zhang J; Wang Y; Li L; Zhang R; Guo R; Li H; Han Q; Teng G; Liu F
Ren Fail; 2018 Nov; 40(1):243-251. PubMed ID: 29633887
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Pathological Characteristics of Patients With Nonproteinuric Diabetic Nephropathy.
Chang DY; Li MR; Yu XJ; Wang SX; Chen M; Zhao MH
Front Endocrinol (Lausanne); 2021; 12():761386. PubMed ID: 34764941
[TBL] [Abstract][Full Text] [Related]
12. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
13. Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline.
Misra PS; Szeto SG; Krizova A; Gilbert RE; Yuen DA
BMC Nephrol; 2020 Jul; 21(1):285. PubMed ID: 32682403
[TBL] [Abstract][Full Text] [Related]
14. Association between serum alkaline phosphatase and renal outcome in patients with type 2 diabetes mellitus.
Zhao L; Li L; Ren H; Zou Y; Zhang R; Wang S; Xu H; Zhang J; Liu F
Ren Fail; 2020 Nov; 42(1):818-828. PubMed ID: 32781868
[TBL] [Abstract][Full Text] [Related]
15. A retrospective cohort study on the pathology and outcomes of type 2 diabetic patients with renal involvement.
Li M; Li CM; Ye ZC; Rao JL; Peng H; Lou TQ
Int Urol Nephrol; 2021 Feb; 53(2):333-341. PubMed ID: 33021708
[TBL] [Abstract][Full Text] [Related]
16. DIABETIC RETINOPATHY, CLASSIFIED USING THE LESION-AWARE DEEP LEARNING SYSTEM, PREDICTS DIABETIC END-STAGE RENAL DISEASE IN CHINESE PATIENTS.
Zhao L; Ren H; Zhang J; Cao Y; Wang Y; Meng D; Wu Y; Zhang R; Zou Y; Xu H; Li L; Zhang J; Cooper ME; Tong N; Liu F
Endocr Pract; 2020 Apr; 26(4):429-443. PubMed ID: 31968187
[No Abstract] [Full Text] [Related]
17. Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort Study.
Yamanouchi M; Furuichi K; Hoshino J; Toyama T; Hara A; Shimizu M; Kinowaki K; Fujii T; Ohashi K; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Hisano S; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Mise K; Makino H; Matsuo S; Ubara Y; Wada T;
Diabetes Care; 2019 May; 42(5):891-902. PubMed ID: 30833372
[TBL] [Abstract][Full Text] [Related]
18. Liver fibrosis is closely related to metabolic factors in metabolic associated fatty liver disease with hepatitis B virus infection.
Lv H; Jiang Y; Zhu G; Liu S; Wang D; Wang J; Zhao K; Liu J
Sci Rep; 2023 Jan; 13(1):1388. PubMed ID: 36697471
[TBL] [Abstract][Full Text] [Related]
19. Gut microbial products valerate and caproate predict renal outcome among the patients with biopsy-confirmed diabetic nephropathy.
Zhong C; Bai X; Chen Q; Ma Y; Li J; Zhang J; Luo Q; Cai K
Acta Diabetol; 2022 Nov; 59(11):1469-1477. PubMed ID: 35947193
[TBL] [Abstract][Full Text] [Related]
20. Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy.
Zhao L; Zhang Y; Liu F; Yang H; Zhong Y; Wang Y; Li S; Su Q; Tang L; Bai L; Ren H; Zou Y; Wang S; Zheng S; Xu H; Li L; Zhang J; Chai Z; Cooper ME; Tong N
J Endocrinol Invest; 2021 Dec; 44(12):2709-2723. PubMed ID: 34043214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
